Optical Property Patents (Class 436/805)
-
Patent number: 7863059Abstract: A target substance detection method for detecting a target substance in a specimen, comprises the steps of contacting with a specimen a target substance detecting element comprised of a base, a metal structure and a first capturing body for capturing a target substance; contacting with the target substance detecting element a labeling material comprised of a labeling substance and a second capturing body for capturing a target substance; and acquiring an absorption spectrum (A) of the target substance detecting element contacted with the specimen and the labeling material, wherein the employed labeling substance is a substance that a slope of a tangent of an absorption spectrum (C) of the labeling substance at a peak wavelength (?z) of an absorption spectrum (B) of the target substance detecting element is larger than zero.Type: GrantFiled: May 16, 2008Date of Patent: January 4, 2011Assignee: Canon Kabushiki KaishaInventors: Mie Okano, Junta Yamamichi
-
Patent number: 7863052Abstract: A grating-based sensor is disclosed that has a grating structure constructed and designed for both evanescent resonance (ER) fluorescence detection and label-free detection applications. Some embodiments are disclosed which are optimized for ER detection in an air mode, in which the sample is dry. Other embodiments are optimized for ER detection in liquid mode, in which the sample is suspended in liquid medium such as water. One and two-dimensional gratings are also disclosed, including gratings characterized by unit cells with central posts, central holes, and two-level, two-dimensional gratings. A readout system for such sensors is also disclosed. One embodiment includes a first light source optimized for collecting label-free detection data, a second light source optimized for collecting ER fluorescence amplification data, and at least one detector. In one embodiment, the detector is an imaging system and includes a CCD camera for collecting both ER and label-free data.Type: GrantFiled: July 20, 2006Date of Patent: January 4, 2011Assignee: SRU Biosystems, Inc.Inventors: Stephen C. Schulz, Brian T. Cunningham, Lance G. Laing, Peter Y. Li, Brant Binder, Gangadhar Jogikalmath, Alex Borsody
-
Patent number: 7842512Abstract: A method for photochemical reactor characterization includes an application of using dyed microspheres exposed to UV irradiation under a collimated-beam system. Particle specific fluorescence intensity measurements are conducted using samples form the collimated beam and flow-through reactor results using flow cytometry. A numerical model may be used to simulate the behavior of the reactor system to provide a particle-tracking algorithm to interrogate the flow and intensity field simulations for purposes of developing a particle specific estimate of the dose delivery. A method for measuring UV dose distribution delivery in photochemical reactors is provided that includes introducing microspheres labeled with a photochemically-active compound in a UV reactor. The labeled microspheres are harvested downstream of the irradiated zone of a UV reactor and exposed to UV irradiation under a collimated beam of UV irradiation.Type: GrantFiled: March 26, 2005Date of Patent: November 30, 2010Assignee: Purdue Research FoundationInventors: Ernest R. Blatchley, III, Chengyue Shen, Zorana Naunovic, Lian-Shin Lin, Dennis A. Lyn, Donald E. Bergstrom, Shiyue Fang, Yousheng Guan, Joseph Paul Robinson, Kathyrn E. Ragheb, Gerald J. Gregori
-
Patent number: 7838285Abstract: Apparatus and method employing gel electrophoresis and optical imaging techniques to measure the amount of biomaterial that attaches to specified locations on a detector slide and to determine the molecular weight of the molecules at those locations.Type: GrantFiled: April 24, 2006Date of Patent: November 23, 2010Assignee: Maven Biotechnologies LLCInventors: Shane Dultz, David Ralin, William Rassman
-
Patent number: 7833711Abstract: The invention is directed to a method and device for simultaneously testing a sample for the presence, absence, and/or amounts of one or more of a plurality of selected analytes. The invention includes, in one aspect, a device for detecting or quantitating a plurality of different analytes in a liquid sample. Each chamber may include an analyte-specific reagent effective to react with a selected analyte that may be present in the sample, and detection means for detecting the signal. Also disclosed are methods utilizing the device.Type: GrantFiled: April 7, 2006Date of Patent: November 16, 2010Assignee: Applied Biosystems, LLCInventors: Timothy M. Woudenberg, Michael Albin, Reid B. Kowallis, Yefim Raysberg, Robert P. Ragusa, Emily S. Winn-Deen
-
Patent number: 7829326Abstract: An encoded carrier includes a code region having a code, and a reaction region separate from the coded region, the reaction region having a variation in its refractive index or dielectric constant in a direction generally parallel to the surface of the reaction region.Type: GrantFiled: August 11, 2004Date of Patent: November 9, 2010Assignee: Kabushiki Kaisha ToshibaInventor: Carl Edward Norman
-
Patent number: 7829327Abstract: An optical waveguide type antibody chip includes a transparent substrate, an incident-side optical element and an emitting-side optical element placed at a distance from each other on a primary face of the substrate, a water repellent resin film formed on the primary face of the substrate including an optical waveguide layer formed between the optical elements, the water repellent resin film includes a reaction hole having exposed the optical waveguide layer on its bottom and a frame-shaped trench surrounding the reaction hole, a rectangular frame-shaped cell wall which is fixed in the trench of the water repellent resin film and which forms a cell capable of infusion and discharge of a specimen solution together with the reaction hole, and an antibody immobilization layer formed on the bottom of the reaction hole, the surface of the antibody immobilization layer being masked with at least a buffer agent and a salt.Type: GrantFiled: March 13, 2008Date of Patent: November 9, 2010Assignee: Kabushiki Kaisha ToshibaInventors: Ikuo Uematsu, Masatoshi Sakai, Shingo Kasai
-
Patent number: 7824925Abstract: Materials and methods are provided for producing patterned multi-array, multi-specific surfaces for use in diagnostics. The invention provides for electrochemiluminescence methods for detecting or measuring an analyte of interest. It also provides for novel electrodes for ECL assays. Materials and methods are provided for the chemical and/or physical control of conducting domains and reagent deposition for use multiply specific testing procedures.Type: GrantFiled: October 31, 2005Date of Patent: November 2, 2010Assignee: Meso Scale Technology LLPInventors: Jacob N. Wohlstadter, James Wilbur, George Sigal, Mark Martin, Liang-Hong Guo, Alan Fischer, Jon Leland, Mark A. Billadeau, Larry R. Helms, Ramin Darvari
-
Patent number: 7816149Abstract: A nanobioprocessor for protein and cell therapy comprises a selectively coated quantum dot having selected band gap energies, characteristic absorption, emission spectra and outer coatings for therapy and diagnostic purposes in biophotonics and nanomedicine, and an electromagnetic radiation and detector source configured to remotely heat and/or selectively excite the quantum dot to associate with target specific misfolded or anomalous proteins, diseased cells and tissue.Type: GrantFiled: March 29, 2005Date of Patent: October 19, 2010Assignee: Applied Photonics Worldwide, Inc.Inventors: Reinhard Bruch, Jutta Gietl
-
Patent number: 7807473Abstract: A method of quantitatively measuring the concentration of a chemical species in a sample solution with a sensor film. A hydrogel sensor film is prepared having a chemical composition comprising an indicator that changes its optical property in the ultra-violet, visible or near-infrared spectral range upon being exposed to the chemical species in the sample solution. The film is exposed to a fixed amount of the sample solution. The concentration of the chemical species in the sample solution is quantified using the average absorbance measured from the sensor film.Type: GrantFiled: October 26, 2005Date of Patent: October 5, 2010Assignee: General Electric CompanyInventors: Radislav A. Potyrailo, Timothy M. Sivavec, Caibin Xiao, Theodore J. Cecconie, Lamyaa Hassib, Andrew M. Leach, David B. Engel
-
Patent number: 7807103Abstract: A method of determining allergen activity in dust comprises: providing a dust sample; extracting from the dust sample at least one breakdown component or proteins or peptides; reacting the extracted at least one breakdown component with a colorimetric amine detection reagent such as TNBSA; and quantitatively measuring the intensity of any resulting coloration. The allergen activity may be gauged by the intensity of coloration.Type: GrantFiled: June 12, 2006Date of Patent: October 5, 2010Assignee: Life Safety Distribution AGInventor: Ramin Pirzad
-
Patent number: 7803633Abstract: A screening device for performing an immunoassay test to detect the presence of a compound in a body fluid. The device includes a holder for removably receiving a membrane to which the fluid has been applied. Light is directed to the membrane. A photodetector measures the concentration of the light reflected back from the membrane. Specifically, the concentrations of reflected light from a control zone and a test zone are measured. Signals representative of the measured light concentrations are applied to a processor. If a specified concentration of predetermined light from a control zone on the membrane is detected, the processor considers the test to be successful. In the test is successful, the processor, based upon the measured concentration of reflected light from the test zone, generates data representative of the presence of the compound.Type: GrantFiled: April 30, 2008Date of Patent: September 28, 2010Assignee: Cozart Bioscience LimitedInventors: Robin James Spivey, Christopher William Hand, Dene Baldwin, Osborn Pierce Jones
-
Patent number: 7794660Abstract: A fluid content monitor including a cuvette, a calorimeter adapted to generate a signal indicative of contents of a fluid sample contained in the cuvette, a container for holding a reagent, and a pump assembly for delivering reagent from the container to the cuvette. The pump assembly includes a tube extending from the container to the cuvette, check valves preventing reverse flow in the tube, and a hammer driven by a solenoid for repetitively compressing the tube to pump reagent to the cuvette. The cuvette can be removed for cleaning and replacement.Type: GrantFiled: January 12, 2007Date of Patent: September 14, 2010Assignee: HF Scientific, Inc.Inventors: Rowan Connelly, Joel Leal
-
Patent number: 7790442Abstract: A bacteriorhodopsin based chemical sensing architecture based upon the collective response of bacteriorhodopsin and a number of its mutants; the wild type protein and a selection of genetically-engineered variants was able to respond differentially to a selection of amines. The observable response to the presence of a target chemical was manifested through a modulation of bacteriorhodopsin's photokinetic properties, which are monitored through pump-probe techniques using a custom prototype flash photolysis system. Differential responsivity exists at two levels; (1) bacteriorhodopsin proteins (wild-type and genetically-engineered variants) respond differentially upon exposure of a target chemical, and (2) the response pattern exhibited by the proteins differs from chemical to chemical. This dichotomy forms the basis for a BR-mediated chemical sensing technology that is highly sensitive and selective and may therefore discriminate between different chemicals.Type: GrantFiled: July 19, 2007Date of Patent: September 7, 2010Assignee: Syracuse UniversityInventors: Jeffrey A. Stuart, Duane Marcy, Robert R. Birge
-
Patent number: 7790406Abstract: A grating-based sensor is disclosed that has a grating structure constructed and designed for both evanescent resonance (ER) fluorescence detection and label-free detection applications. One and two-dimensional gratings are also disclosed, including gratings characterized by unit cells with central posts, central holes, and two-level, two-dimensional gratings. A readout system for such sensors is also disclosed. Various applications for the biosensors are described, including cell-based assays for assessing the effect of drug compounds on cell function. A biosensor embodiment optimized for a luminescent response at two different wavelengths is also described. Such luminescent response could be produced by fluorescence (either native or from an attached fluorophore), phosphorescence, chemi-luminescence, or other luminescence technology. Two different luminescence technologies could be combined on the same biosensor chip.Type: GrantFiled: June 15, 2007Date of Patent: September 7, 2010Assignee: SRU Biosystems, IncInventors: Brian T. Cunningham, Peter Y. Li, Lance G. Laing, Gangadhar Jogikalmath
-
Patent number: 7785904Abstract: The present invention relates to hydrophilic, high quantum yield acridinium compounds. It has been discovered that the placement of electron-donating groups in the acridinium ring system increases the amount of light that is emitted by the corresponding acridinium compound when its chemiluminescence is triggered by alkaline peroxide. More specifically, it has been found that the placement of one or two hydrophilic, alkoxy groups at the C-2 and/or C-7 position of the acridinium ring system of acridinium compounds increases their quantum yield and enhances the aqueous solubility of these compounds. The present hydrophilic, high quantum yield, acridinium compounds are useful chemiluminescent labels for improving the sensitivity of immunoassays.Type: GrantFiled: June 19, 2007Date of Patent: August 31, 2010Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Anand Natrajan, Qingping Jiang, David Sharpe, James Costello
-
Patent number: 7781226Abstract: Described herein is an analyte detection device and method related to a portable instrument suitable for point-of-care analyses. In some embodiments, a portable instrument may include a disposable cartridge, an optical detector, a sample collection device and/or sample reservoir, reagent delivery systems, fluid delivery systems, one or more channels, and/or waste reservoirs. Use of a portable instrument may reduce the hazard to an operator by reducing an operator's contact with a sample for analysis. The device is capable of obtaining diagnostic information using cellular- and/or particle-based analyses and may be used in conjunction with membrane- and/or particle-based analysis cartridges. Analytes, including proteins and cells and/or microbes may be detected using the membrane and/or particle based analysis system.Type: GrantFiled: December 22, 2004Date of Patent: August 24, 2010Assignee: The Board of Regents of the University of Texas SystemInventors: John T. McDevitt, Nick Christodoulides, Pierre Floriano, Karri L. Ballard, Bruce Bernard, Glenn Simmons
-
Patent number: 7776618Abstract: The invention comprises a device for detecting an analyte in a liquid sample deposited on a first portion of the device for transport to a second portion of the device that is in fluid contact with the first portion. In specific embodiments, the device comprises a labeled conjugate comprising a binding member reactive with a first epitope of the analyte and a label comprising a gold colloid, preferably having a mean particle size of 50 nm to 100 nm. In further embodiments, the device comprises a capture component comprising polymerized streptavidin. The diagnostic device is particularly useful in the preparation of pregnancy test kits.Type: GrantFiled: March 1, 2007Date of Patent: August 17, 2010Assignee: Church & Dwight Co., Inc.Inventors: Albert Nazareth, Timothy Snowden, Yea-shun Cheng
-
Patent number: 7776528Abstract: Compositions and methods for increasing the fluorescence intensity of molecules are provided. In particular, compositions and methods directed to increasing the intrinsic fluorescence of biomolecules and low quantum yield fluorophores are described. The intrinsic fluorescence of biomolecules is increased by positioning a metal particle and a biomolecule at a distance apart sufficient to increase the radiative decay rate of the biomolecule. Methods for the identification of nucleic acids are also provided. The compositions and methods can also be used to increase the emission of any fluorophore, such as the extrinsic probes used to label biomolecules.Type: GrantFiled: November 18, 2004Date of Patent: August 17, 2010Assignee: University of Maryland, BaltimoreInventor: Joseph R. Lakowicz
-
Patent number: 7771985Abstract: Disclosed are devices for detecting the presence of a preselected analyte in a fluid sample. The devices comprise a substrate microfabricated to define a sample inlet port, and a mesoscale flow system that includes a sample flow channel extending from the inlet port. The mesoscale flow system further includes an analyte detection region in fluid communication with the flow channel comprised of a binding moiety for specifically binding the analyte. The detection region is constructed with a mesoscale dimension sufficiently small to enhance binding of the binding moiety and the analyte. The binding moiety may be immobilized in the detection region. The mesoscale detection systems of the invention may be used in a wide range of applications, including the detection of cells or macromolecules, or for monitoring reactions or cell culture growth.Type: GrantFiled: April 4, 2007Date of Patent: August 10, 2010Assignee: Trustees of the University of PennsylvaniaInventors: Peter Wilding, Larry J. Kricka, Jay N. Zemel
-
Patent number: 7771939Abstract: Described are methods of assay design and assay image correction, useful for multiplexed genetic screening for mutations and polymorphisms, including CF-related mutants and polymorphs, using an array of probe pairs (in one aspect, where one member is complementary to a particular mutant or polymorphic allele and the other member is complementary to a corresponding wild type allele), with probes bound to encoded particles (e.g., beads) wherein the encoding allows identification of the attached probe. The methods relate to avoiding cross-hybridization by selection of probes and amplicons, as well as separation of reactions of certain probes and amplicons where a homology threshold is exceeded. Methods of correcting a fluorescent image using a background map, where the particles also contain an optical encoding system, are also disclosed.Type: GrantFiled: May 23, 2006Date of Patent: August 10, 2010Assignee: Bioarray Solutions, Ltd.Inventors: Ghazala Hashmi, Michael Seul
-
Patent number: 7759133Abstract: Methods of detecting and/or quantifying an IgE antibody present in a liquid sample. The IgE antibody is specific to a ligand in the form of an antigen, an antibody, or a hapten. These methods can be used for monitoring and evaluating the immunological status of a subject.Type: GrantFiled: December 21, 1999Date of Patent: July 20, 2010Assignee: ALK-Abello A/SInventor: Joost Van Neerven
-
Patent number: 7759129Abstract: The invention provides an optical sensor for detecting chemical reaction activity, including, e.g., enzyme activity and catalytic or reactive molecule activity. An optical sensor of the invention includes a porous photonic film that produces a predetermined spectral reflectance response. In preferred embodiments, the film has a chemical coating (such as a hydrophobic layer) within its pores with an affinity for the reaction product(s) of the catalytic or otherwise reactive analyte A coating can also act as a protective layer in preferred embodiment. A thin substrate susceptible to reaction by at least one analyte of interest is on the surface of the thin film to block pores of the thin film. A method of detecting chemical reaction activity of the invention exposes the optical sensor to an analyte of interest, such as an enzyme or otherwise catalytic or reactive molecule.Type: GrantFiled: January 10, 2007Date of Patent: July 20, 2010Assignee: The Regents of the University of CaliforniaInventors: Michael J. Sailor, Manuel M. Orosco, Claudia Pacholski, Gordon M. Miskelly
-
Patent number: 7754472Abstract: The invention relates to a device for detecting one or several analytes in a sample, characterized in that it comprises one or more reaction chambers and/or one or more reagent application channels, and one or more capillary systems and one or more negative vessels. The invention also relates to a method for detecting one or more analytes in a sample fluid by visualization of agglutination, characterized in that a) the sample fluid is brought into contact with a reagent, b) the reaction mixture is exposed to the effects of gravitation or magnetism, wherein the reaction mixture is strained through the capillary system of the inventive device with a negative vessel connected to the inventive device, and c) the reaction between the analyte and the reagent is determined. The invention also relates to one such method wherein the reaction mixture is brought into contact with another reagent during step b).Type: GrantFiled: February 2, 2005Date of Patent: July 13, 2010Assignee: Medion Diagnostics AGInventors: Peter Schwind, Philippe Monod
-
Patent number: 7749771Abstract: Disclosed is a device, for detecting an analyte in a sample, comprising a sample pad for collecting the sample, a test strip coupled to the sample pad, and a housing enclosing and allowing visualization of the test strip. The sample pad can include one or more markings for determining the amount of sample collected. The device can also include a run fluid container that fits over the sample pad and forms an air-tight seal around the housing. Further, the device can include a second sample pad/test strip combination for detection of a second analyte. Also disclosed are methods for detecting an analyte in a sample using the device.Type: GrantFiled: April 7, 2006Date of Patent: July 6, 2010Assignee: Rapid Medical Diagnostics CorporationInventors: Anthony Burgess-Cassler, Lawrence A. Salvo, Luis Alejandro Agudelo
-
Patent number: 7736910Abstract: The present invention comprises novel “one-step” methods for the production of gold sol and gold sol conjugates. The methods disclosed herein produce gold sol and colloidal gold conjugates with product with yields on the order of about 20 ODs. Since current methods in the art yield conjugates at concentrations on the order of about 2 ODs, the present invention represents an approximately 10-fold increase in production over conventional methods. The novel method provided herein also does not result in the production of undesired aggregate by-products that, in conventional methods, must be removed via centrifugation, filtration or other means. The new method is therefore less labor intensive and requires less time to complete than standard methods in the art for synthesizing pure colloidal gold conjugates.Type: GrantFiled: October 4, 2005Date of Patent: June 15, 2010Assignee: Calypte Biomedical CorporationInventor: Leslie Kirkegaard
-
Patent number: 7727775Abstract: Labels and methods of producing labels for use in clinical, analytical and pharmaceutical development assays are provided. Labels may comprise shape-encoded particles which may be coupled to ligands such as DNA, RNA and antibodies, where different shapes are used to identify which ligand(s) are present. Labels may also comprise reflectors, including retroreflectors and retroreflectors susceptible to analyte-dependent assembly for efficient homogeneous assays.Type: GrantFiled: October 25, 2005Date of Patent: June 1, 2010Inventors: Richard C. Willson, Paul Ruchhoeft
-
Patent number: 7723122Abstract: It is an object of the present invention to provide a method for analyzing the interaction of a test substance with a ligand by analyzing a phenomenon whereby multiple test substances are simultaneously adsorbed to a ligand. The present invention provides a method for analyzing the interaction of test substances with a ligand by measuring the change in the surface plasmon resonance using a surface plasmon resonance measurement device wherein the above-described method comprises: supplying a solution containing two or more types of test substances after supplying a solution containing no test substances; measuring the change in the surface plasmon resonance; and analyzing the difference between the change in the surface plasmon resonance that is predicted from the adsorption rate constant (ka) and dissociation rate constant (kd) of each of the test substances that had previously been measured and the change in the surface plasmon resonance that has actually been measured.Type: GrantFiled: August 30, 2005Date of Patent: May 25, 2010Assignee: FUJIFILM CorporationInventor: Hirohiko Tsuzuki
-
Patent number: 7724319Abstract: A method of forming a liquid crystal device, includes: contacting an aqueous solution comprising a surfactant and a receptor molecule with a top surface of a liquid crystal. The liquid crystal is in a holding compartment of a substrate, and the receptor molecule is adsorbed on the top surface of the liquid crystal forming an interface between the liquid crystal and the aqueous solution. The receptor molecule is different than the surfactant. A method of detecting a compound in a flowing stream includes passing an aqueous solution over a top surface of a liquid crystal in a holding compartment of a substrate. The method also includes determining whether a change in the orientation of the liquid crystal occurs as the aqueous solution is passed over the top surface of the liquid crystal. A change in the orientation of the liquid crystal indicates the presence of the compound in the flowing stream.Type: GrantFiled: November 26, 2008Date of Patent: May 25, 2010Assignee: Wisconsin Alumni Research FoundationInventors: Nicholas L. Abbott, Jeffrey M. Brake
-
Patent number: 7718440Abstract: Performing high-resolution determination of the relative shift of the spectral properties of a biosensor. The shift in the resonance peak of the biosensor is indicative of the amount of material bound to the surface of the biosensor. A preferred biosensor is a Guided Mode Resonant Filter Biosensor (GMRFB). In one aspect of the invention, curve fitting is used to determine the relative location of the spectrum of the unexposed biosensor with respect to those spectra that are altered (e.g., shifted) by the presence of materials bound to the surface of the biosensor. In an alternative embodiment, the cross correlation function is used to detect spectral peak offsets between a reference spectrum and a spectrum measured from an exposed biosensor. In yet another alternative, maximal likelihood estimation techniques are used to determine the spectral shift or offs.Type: GrantFiled: May 15, 2007Date of Patent: May 18, 2010Assignee: SRU Biosystems, Inc.Inventors: Homer Paul Pien, William C. Karl, Derek Puff, Peter Li, Brian Cunningham
-
Patent number: 7718443Abstract: Disclosed is an assay device to determine the presence of at least one analyte of interest in a liquid sample, the device comprising means for generating a first signal (the ‘test’ signal) which indicates the presence and/or amount of analyte of interest in the sample; and means for generating a second signal, the generation of which second signal indicates both (a) the test has been successfully conducted, and that (b) sufficient time has elapsed following contact of the assay device with the liquid sample for the test to be read and the first signal to have been properly generated.Type: GrantFiled: January 9, 2003Date of Patent: May 18, 2010Assignee: Inverness Medical Switzerland GmbHInventors: Natalie Elizabeth Beesley, Barry Sinclair Brewster, Susan Catrin Day, Adrian Leslie Walker
-
Patent number: 7718355Abstract: There is provided a method of detecting a pathogenic microorganism in real-time, using a modified flow-type surface plasmon resonance (SPR) biosensor, comprising the steps of: i) performing, in a batch-type, an immune reaction of a pathogenic microorganism and an antibody thereto; ii) selectively separating the pathogenic microorganism bound with the antibody; and iii) binding the pathogenic microorganism bound with the antibody on a surface of a chip of a flow-type SPR sensor system in real-time.Type: GrantFiled: December 28, 2006Date of Patent: May 18, 2010Assignee: Sungkyunkwan UniversityInventors: Sang-jun Sim, Chang-deok Kang
-
Patent number: 7713751Abstract: A method for detecting binding of biological and/or chemical components of liquid or gaseous mixtures and solutions, which are of mainly biological origin and/or determine parameters of living activity of biological objects, to substances that bind said components due to a biological, chemical or physical interaction; and analysis of mixtures and solutions to determine presence of biological and/or chemical components. Binding substances are arranged on a surface of or inside a sensor layer, which changes its thickness due to the binding being detected; the layer is affected by light of different wavelengths; a signal due to interference on the sensor layer is registered in the reflected or transmitted light.Type: GrantFiled: April 14, 2008Date of Patent: May 11, 2010Inventors: Petr Ivanovich Nikitin, Boris Georgievich Gorshkov
-
Patent number: 7708864Abstract: The present invention is a method to identify a refinery solid foulant of unknown composition including the following steps: obtaining a solid foulant sample, removing trapped feed from the sample with a solvent to obtain an insoluble sample, scanning the insoluble sample with a scanning electron microscope and energy dispersive x-rays, performing a thermal gravimetric analysis including an ash test on the insoluble sample to determine the presence of polymer, coke and inorganic elements, performing an elemental analysis on the insoluble sample for the elements carbon, hydrogen, sulfur, nitrogen, halogens, and metals, performing an optical microscopy on the insoluble sample to determine the presence of wax, asphaltenes, anisotropic coke and isotropic coke, and identifying the solid foulant.Type: GrantFiled: July 1, 2005Date of Patent: May 4, 2010Assignee: ExxonMobil Research & Engineering CompanyInventors: Glen Brons, Leo D. Brown, Himanshu Joshi, Raymond J. Kennedy, Tom Bruno, Thomas M. Rudy
-
Patent number: 7700298Abstract: The invention relates to analytical methods in which the partition of a labeled substance between a liquid and a solid phase is determined. The assays include solid-phase reagents which can be particulate or monolithic such as, for example, a coated tube. Assays of this type are known per se to the person skilled in the art and include immunoassays and immunometric assays.Type: GrantFiled: February 16, 2006Date of Patent: April 20, 2010Assignee: Siemens Healthcare Diagnostics Products GmbHInventor: Thomas Wissel
-
Patent number: 7700373Abstract: The present invention relates to an apparatus for use in an assay comprising: (a) at least one first receptacle comprising a fluid inlet and a fluid outlet, (b) a porous membrane, and (c) at least one analyte-specific binding agent, characterised in that said at least one analyte-specific binding agent is immobilised on the underside of said porous membrane relative to the fluid inlet; and to methods of performing said assay.Type: GrantFiled: May 21, 2004Date of Patent: April 20, 2010Assignee: Nalia Systems Ltd.Inventors: Jeffrey D. McBride, Francis Guy Gabriel, Peter J. Delves, John L. A. Fordham, Ian A. Cree, Keith Rawson
-
Patent number: 7695973Abstract: The present invention provides methods for quantitation of glycated protein in a biological sample using a solid support matrix by making a first bound protein measurement total bound protein under conditions where both glycated and non-glycated protein bind to the support in making a second bound protein measurement under conditions where glycated protein is bound to the support and non-glycated protein is not substantially bound. Diagnostic devices and kits comprising the methods of the present invention are also provided.Type: GrantFiled: February 7, 2007Date of Patent: April 13, 2010Assignee: Scripps Laboratories, Inc.Inventors: Ralph P. McCroskey, Cameron E. Melton
-
Patent number: 7670853Abstract: A system for treating a blood sample (700) having an analyte of interest comprises a strip (200) having a membrane (218), respective portions (216, 220 and 222, or 300) which are provided for receiving the sample, for lysing cells of the sample to liberate hemoglobin, and for capturing glycated hemoglobin. The latter two portions (220 and 222, or 300) of the membrane are treated with lysing and capture agents, respectively. A portion of the strip (214 or 230 or 240) is provided for holding an eluting agent and for releasing the agent upon a release condition. A system for detecting analyte comprises an optical subsystem (550) that is aligned with the strip to provide a signal corresponding to an amount of analyte, and an electronic subsystem (650) for processing the signal (560) to provide a result, such as an amount or percentage of glycated hemoglobin.Type: GrantFiled: November 5, 2003Date of Patent: March 2, 2010Assignee: Abbott Diabetes Care Inc.Inventor: Arvind N. Jina
-
Patent number: 7670843Abstract: A method of and device for sampling polycyclic aromatic hydrocarbons (PAHs) in the ambient environment, the method including: (a) providing a polymer film for collecting the PAHs; (b) exposing the polymer film to a gas containing the PAHs, and (c) performing an analysis of the PAHs collected by the polymer film, the analysis being selected from the group consisting of fluorescence analysis and Fourier Transform Imaging Microscopy (FT-SIM).Type: GrantFiled: March 4, 2004Date of Patent: March 2, 2010Assignee: Technion Research and Development Foundation Ltd.Inventors: Israel Schechter, Chanan Sluszny, Valery Bulatov, Vladimir Gridin
-
Patent number: 7662643Abstract: A membrane-based assay device for detecting the presence or quantity of an analyte residing in a test sample is provided. The device utilizes a chromatographic zone on which is disposed a plurality of microporous particles. The chromatographic zone can effectively reduce the “hook effect” in a simple, efficient, and relatively inexpensive manner. In particular, the plurality of microporous particles allows larger-sized analyte/probe complexes to reach the detection zone before the uncomplexed analyte. Because the uncomplexed analyte is substantially inhibited from competing with the complexes for the binding sites at the detection zone, the incidence of “false negatives” may be limited, even at relatively high analyte concentrations.Type: GrantFiled: July 20, 2007Date of Patent: February 16, 2010Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Ning Wei, Yanbin Huang
-
Patent number: 7655478Abstract: In a sensor device and a sensing method capable of simultaneously extracting plural pieces of information including information about the presence/absence, distribution, and so on, of targets, in case of measuring changes in nature of a detecting portion (11) upon coupling with targets (a and b), information about changes in quantities of the targets (a and b) with time is extracted in addition to information about the presence/absence, distribution, and so on, of the targets (a and b) from geometrical structures of the detecting portion (11), such as locations and/or shapes of bonding sites (A and B) for selectively coupling with the targets (a and b), respectively.Type: GrantFiled: April 9, 2004Date of Patent: February 2, 2010Assignee: Sony CorporationInventor: Yuuki Watanabe
-
Patent number: 7651869Abstract: Optical assay apparatus and methods are provided having an optical assay cup for detecting analytes in a sample fluid. The cup's sidewall may include an optical waveguide having a detection coating on its inner surface. During use, the waveguide receives evanescent or darkfield interrogation light, interrogates at least part of cup's interior volume with it, and emits signal light as a function of the analytes. The detection coating may have fluid or non-fluid detection layers, at least part of which may form at least part of a waveguide for the interrogation light. The cup may be spun during use, such as to centrifugally-concentrate any high-density analytes towards cup's sidewall. The assay apparatus may further include an interrogation light source, a cover or spinning apparatus for the cup, and an optical detector for the signal light.Type: GrantFiled: March 14, 2006Date of Patent: January 26, 2010Assignee: Research International, Inc.Inventors: Elric W. Saaski, David A. McCrae
-
Patent number: 7645612Abstract: The invention is related to different embodiments of a kit for the simultaneous qualitative and/or quantitative determination of a multitude of analytes comprising a sensor platform comprising an optical thin-film waveguide with a layer (a) transparent at least at an excitation wavelength on a layer (b) with lower refractive index than layer (a), also transparent at least at said excitation wavelength, and at least one grating structure (c) modulated in said layer (a), for the incoupling of said excitation light into layer (a), at least one array of biological or biochemical or synthetic recognition elements immobilized in discrete measurement areas (d) directly or by means of an adhesion-promoting layer on layer (a), for specific recognition and/or binding of said analytes and/or for specific interaction with said analytes, means for laterally resolved referencing of the excitation light intensity available in the measurement areas, and optionally means for the calibration of one or more luminescences genType: GrantFiled: April 4, 2008Date of Patent: January 12, 2010Assignee: Bayer Technology Services GmbHInventors: Michael Pawlak, Eginhard Schick, Andreas Peter Abel, Gert Ludwig Duveneck, Markus Ehrat, Gerhard Matthias Kresbach, Eveline Schürmann-Mader, Martin Andreas Bopp
-
Patent number: 7629180Abstract: A diagnostic and testing apparatus and related methods for the use of the same are disclosed which derive and use antibodies to equine albumin and equine hemoglobin in testing apparatus, kits, and methods for detecting and localizing gastric and colonic ulcers or bleeding in horses. Fecal droppings from a horse to be tested are placed in a container together with a buffered liquid solution and mixed thoroughly, following which several drops of liquid from the container are placed into a test kit. Visual markers in the test kits signify the detection of the indicators equine hemoglobin and equine albumin, which are respectively indicative of the presence of gastric and/or colonic ulcers or bleeding.Type: GrantFiled: November 28, 2006Date of Patent: December 8, 2009Assignee: Freedom Health, LLCInventors: Franklin L. Pellegrini, Scott D. Carter
-
Patent number: 7622294Abstract: A microsphere-based analytic chemistry system and method for making the same is disclosed in which microspheres or particles carrying bioactive agents may be combined randomly or in ordered fashion and dispersed on a substrate to form an array while maintaining the ability to identify the location of bioactive agents and particles within the array using an optically interrogatable, optical signature encoding scheme. A wide variety of modified substrates may be employed which provide either discrete or non-discrete sites for accommodating the microspheres in either random or patterned distributions. The substrates may be constructed from a variety of materials to form either two-dimensional or three-dimensional configurations. In a preferred embodiment, a modified fiber optic bundle or array is employed as a substrate to produce a high density array. The disclosed system and method have utility for detecting target analytes and screening large libraries of bioactive agents.Type: GrantFiled: August 17, 2004Date of Patent: November 24, 2009Assignee: Trustees of Tufts CollegeInventors: David R. Walt, Karri Lynn Ballard
-
Patent number: 7622259Abstract: The present invention relates to a method for detecting von-Willebrand factor (vWF) activity comprising assaying a sample in the presence of a soluble form or portion of glycoprotein Ib(?) (GPIb(?) and ristocetin, or a functionally equivalent substance. Additionally, the invention relates to the use of the aforementioned soluble form or portion of glycoprotein Ib(?), of ristocetin or a functional equivalent substance, of specifically reacting anti-GPIB(?) antibody(ies) and/or of specific binding partners, like specifically reacting anti-vWF antibody(ies) for carrying out the method of the invention. Furthermore, the present invention relates to kits for carrying out the method of the invention.Type: GrantFiled: July 5, 2000Date of Patent: November 24, 2009Assignee: K.U. Leuven Research & DevelopmentInventors: Nancy Cauwenberghs, Karen Vanhoorelbeke, Hans Deckmyn
-
Patent number: 7615376Abstract: In a process for the quantitative optical analysis of fluorescently labelled biological cells 5, a cell layer on a transparent support at the bottom 2 of a reaction vessel 1 is in contact with a solution 3 containing the fluorescent dye 4. The sensitivity of analytical detection can be considerably improved if to the fluorescent dye 4 already present in addition a masking dye 9, which absorbs the excitation light 6 for the fluorescent dye 4 and/or its emission light 7, is added to the solution 3 and/or if a separating layer 10 permeable to the solution and absorbing and/or reflecting the excitation light 6 or the emission light 7 is applied to the cell layer at the bottom 2. This process can also be used for improving the sensitivity in the quantitative optical analysis of a luminescent biological cell layer. The separating layer 10 must in this case be composed such that it has a high power of reflection for the luminescent light 11.Type: GrantFiled: August 27, 2008Date of Patent: November 10, 2009Assignee: Bayer Schering Pharma AktiengesellschaftInventors: Thomas Krahn, Wolfgang Paffhausen, Andreas Schade, Martin Bechem, Delf Schmidt
-
Patent number: 7611907Abstract: A composition is disclosed which is capable of being used for detection, comprising an encapsulated noble metal nanocluster. Methods for preparing the encapsulated noble metal nanoclusters, and methods of using the encapsulated noble metal nanoclusters are also disclosed. The noble metal nanoclusters are preferably encapsulated by a dendrimer or a peptide. The encapsulated noble metal nanoclusters have a characteristic spectral emission, wherein said spectral emission is varied by controlling the nature of the encapsulating material, such as by controlling the size of the nanocluster and/or the generation of the dendrimer, and wherein said emission is used to provide information about a biological state.Type: GrantFiled: June 27, 2003Date of Patent: November 3, 2009Assignee: Georgia Tech Research CorporationInventors: Robert Martin Dickson, Jie Zheng
-
Patent number: 7611905Abstract: A surface plasmon resonance (SPR) assay apparatus has an assay stage, which is loadable with a sensor unit. The sensor unit has a prism, thin film, flow cell and flow channel for flow of sample. A multiple pipette assembly accesses the flow channel in the assay stage, and introduces the sample into the flow channel. A light source applies illuminating light to the thin film to satisfy a total reflection condition. A photo detector receives the illuminating light reflected by the thin film to output a signal. A pressing mechanism presses the sensor unit on the assay stage for holding in a direction of the access of the pipette assembly. The pressing mechanism includes a movable pad for contacting the sensor unit. A slider moves the pad to press the sensor unit. A spring plunger adjusts pressure of the pad to the sensor unit.Type: GrantFiled: May 19, 2006Date of Patent: November 3, 2009Assignee: FUJIFILM CorporationInventors: Yoshiyuki Kunuki, Katsuaki Muraishi
-
Patent number: 7608463Abstract: An optical assay apparatus having an optical filter, an optical sensor with a light ray redirection portion and an assay sensing portion, and a filter to block certain wavelengths of excitation light rays and to pass certain wavelengths of signal recovery light rays from the optical sensor. A method for performing an assay that includes providing at least one assay station, moving the optical sensor into position over a respective fluid in at least one assay station, immersing the assay sensing portion in the respective fluid, and removing the assay sensing portion from the respective fluid.Type: GrantFiled: July 10, 2007Date of Patent: October 27, 2009Assignee: Research International, Inc.Inventor: Elric W. Saaski